Skip to main navigation Skip to search Skip to main content

Preliminary safety and efficacy of Bgb-11417, a novel Bcl-2 inhibitor, in combination with azacitidine in patients with acute myeloid leukemia (AML)

Jake Shortt, Pau Montesinos, Shuh Ying Tan, Teng Fong Ng, Chun Yew Fong, Paul Cannell, Rajeev Rajagopal, Sophia Leitch, Peter T. Tan, Sundra Ramanathan, Robin Gasiorowski, Douglas Stuart Lenton, Tse-Chieh Teh, Jose Antonio Perez-Simon, Carolyn Grove, Xiaojun Huang, Courtney D. DiNardo, Katherine Naidu, Joseph Pariseau, Si ChengYu Liu, Melannie Co, Wai Y. Chan, Haiyi Guo, Andrew H. Wei

Research output: Contribution to journal › Meeting abstract › peer-review

Original languageEnglish
Pages (from-to)3329-3332
Number of pages4
JournalBlood
Volume140
Issue numberSupplement 1
DOIs
Publication statusPublished - 15 Nov 2022
Externally publishedYes
Event64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - New Orleans, United States
Duration: 10 Dec 2022 → 13 Dec 2022

Cite this